Among the measures that were discussed in the meeting was how the Central Drugs Standards Control Organization’s manpower can be efficiently utilised to make the approval faster NEW DELHI: With the Covid-19 pandemic getting the Indian drug regulatory system working in a faster gear, a government panel on Friday considered all the measures taken for faster approval process and use these to overhaul the drug regulatory system, three sources in the know told Mint. “The discussions revolved around what all measures the CDSCO (Central Drugs Standards Control Organization) took to make the whole system faster, and how we can apply these to normal times because a lot of industry officials had expressed satisfaction at the speed of the approval